Washington, Apr 20 : Scientists from University of California, San Diego and the Moores UCSD Cancer Centre have identified a biomaker that may help predict aggressiveness of difficult-to-treat form of leukaemia.
The research team, led by Dr Paul A. Insel, professor of pharmacology and medicine at the UC San Diego School of Medicine, has found that high levels of a enzyme, called PDE7B, in the blood are an indicator that chronic lymphocytic leukemia (CLL) - the most common form of adult leukaemia.